Tag: COPD
Mold Exposure Tied to Worse COPD Outcomes
Mold may increase the risk for flare-ups and hospitalization with chronic obstructive pulmonary disease
Access to Pulmonary Rehab Limited for Many COPD Patients
Overall, 61.5 percent of Medicare beneficiaries have pulmonary rehabilitation center within a 10-mile radius
Asthma Exacerbations, ED Admissions Decreased During Lockdown
Nonpharmaceutical interventions to reduce COVID-19 associated with reduction in admissions for COPD, asthma
ATS Issues Guideline on Home Oxygen Therapy for COPD, ILD
Long-term oxygen therapy strongly recommended for adults with COPD, ILD who have severe chronic resting hypoxemia
Cannabinoid Use Tied to Adverse Outcomes With COPD
In older adults with COPD, cannabinoid use tied to all-cause mortality, hospitalizations
HRRP Tied to Decrease in 30-Day Readmission Rates for COPD
But increase seen in 30-day risk-standardized postdischarge mortality rates for COPD patients
Perrigo Asthma Inhalers Recalled Due to Clog Risk
Some of the recalled albuterol sulfate inhalers stop working after several uses
ATS Issues Recommendations for Noninvasive Ventilation in COPD
Use of nocturnal NIV suggested as well as usual care for patients with chronic stable hypercapnic COPD
Health Expenditures Considerable for Asthma, COPD in U.S. Workers
Annualized total medical expenditures are $7 billion and $5 billion, respectively
Triple Inhaled Therapy Aids in Moderate-to-Very Severe COPD
Benefit seen for twice-daily triple inhaled therapy with glucocorticoid, glycopyrrolate, formoterol
